Antibacterial mass drug administration for child mortality reduction: Opportunities, concerns, and possible next steps

Isaac I. Bogoch; Jürg Utzinger; Nathan C. Lo; Jason R. Andrews

doi:10.1371/journal.pntd.0007315

Loading metrics

Open Access

Viewpoints are opinion pieces grounded in evidence on topics of broad interest to the journal's readership.

See all article types »

Antibacterial mass drug administration for child mortality reduction: Opportunities, concerns, and possible next steps

Isaac I. Bogoch ,

* E-mail: isaac.bogoch@uhn.ca

Affiliations Divisions of General Internal Medicine and Infectious Diseases, Toronto General Hospital, University Health Network, Toronto, Canada, Department of Medicine, University of Toronto, Toronto, Canada

http://orcid.org/0000-0003-1590-6748

⨯
Jürg Utzinger,

Affiliations Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland
⨯
Nathan C. Lo,

Affiliations Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America, Division of Epidemiology, Stanford University School of Medicine, Stanford, California, United States of America
⨯
Jason R. Andrews

Affiliation Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America
⨯

Antibacterial mass drug administration for child mortality reduction: Opportunities, concerns, and possible next steps

Isaac I. Bogoch,
Jürg Utzinger,
Nathan C. Lo,
Jason R. Andrews

Published: May 23, 2019
https://doi.org/10.1371/journal.pntd.0007315

About the Authors

Isaac I. Bogoch

* E-mail: isaac.bogoch@uhn.ca

Affiliations Divisions of General Internal Medicine and Infectious Diseases, Toronto General Hospital, University Health Network, Toronto, Canada, Department of Medicine, University of Toronto, Toronto, Canada

http://orcid.org/0000-0003-1590-6748

Jürg Utzinger

Affiliations Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland

Nathan C. Lo

Affiliations Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America, Division of Epidemiology, Stanford University School of Medicine, Stanford, California, United States of America

Jason R. Andrews

Affiliation Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America

Competing Interests

The authors have declared that no competing interests exist.

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Antimicrobial resistance
Is the Subject Area "Antimicrobial resistance" applicable to this article?

Thanks for your feedback.
Antibacterials
Is the Subject Area "Antibacterials" applicable to this article?

Thanks for your feedback.
Death rates
Is the Subject Area "Death rates" applicable to this article?

Thanks for your feedback.
Helminth infections
Is the Subject Area "Helminth infections" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Trachoma
Is the Subject Area "Trachoma" applicable to this article?

Thanks for your feedback.
Helminths
Is the Subject Area "Helminths" applicable to this article?

Thanks for your feedback.
Helminthic therapy
Is the Subject Area "Helminthic therapy" applicable to this article?

Thanks for your feedback.